2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P99442
    Apolizumab 267227-08-7
    Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro.
    Apolizumab
  • HY-P99456
    Baloramotide 2207581-19-7
    Baloramotide is a recombinant NY-ESO-1 protein containing 182 amino acids. Baloramotide increases the immune response against tumors.
    Baloramotide
  • HY-P99457
    Balstilimab 2148321-77-9 ≥99.0%
    Balstilimab (AGEN2034) is a fully human monoclonal IgG4 antibody against PD-1.
    Balstilimab
  • HY-P99474
    Bertilimumab 375348-49-5
    Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research.
    Bertilimumab
  • HY-P99477
    Bevifimod 2223113-32-2
    Bevifimod (PRTX-100) is a highly purified form of Staphylococcal protein A (SpA). Bevifimod can be used for idiopathic thrombocytopenic purpura (ITP) research.
    Bevifimod
  • HY-P99478
    Bifarcept 163796-60-9
    Bifarcept is an interferon receptor type I (IFN-RI) fusion protein. Bifarcept can bind interferon receptors and prolong its serum half-life.
    Bifarcept
  • HY-P99495
    Cedelizumab 156586-90-2
    Cedelizumab (RWJ 49004) is a IgG4 monoclonal antibody targeting CD4. Cedelizumab has immunosuppressant properties.
    Cedelizumab
  • HY-P99525
    Varisacumab 1610010-60-0
    Varisacumab (R 84) is an antibody. Varisacumab can be used for various biochemical studies
    Varisacumab
  • HY-P99526
    Vapaliximab 336801-86-6
    Vapaliximab (2D10) is a monoclonal antibody against human VAP-1.
    Vapaliximab
  • HY-P99563
    Tibulizumab 1849636-24-3
    Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research.
    Tibulizumab
  • HY-P99572
    Tecaginlimab 2253891-70-0 99.00%
    Tecaginlimab (BNT-312) is a Fc-inert bispecific antibody for dual targeting and conditional stimulation of CD40 and 4-1BB. Tecaginlimab can enhance priming and reactivation of tumor-specific immunity.
    Tecaginlimab
  • HY-P99636
    Gavilimomab 244096-20-6
    Gavilimomab (ABX-CBL) is an IgM murine monoclonal antibody that recognizes CD147 on the cell surface and initiates cell killing through complement-mediated lysis. Gavilimomab can be used for the research of graft-versus-host disease (GVHD).
    Gavilimomab
  • HY-P99679
    Izuralimab 2329669-80-7
    Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1.
    Izuralimab
  • HY-P99692
    Lenercept 156679-34-4
    Lenercept (Ro 45-2081) is a recombinant fusion protein that consists of the soluble TNF-receptor (p55) linked to the Fc portion of human IgG1.
    Lenercept
  • HY-P99726
    Maslimomab 127757-92-0
    Maslimomab is a murine monoclonal antibody targeting T-cell receptor. Maslimomab is an immunosuppressive agent.
    Maslimomab
  • HY-P99728
    Melredableukin alfa 2056881-92-4
    Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of autoimmune hepatitis and ulcerative colitis.
    Melredableukin alfa
  • HY-P99745
    Morolimumab 202833-07-6
    Morolimumab is an IgG1 human anti-RHD/CD240D monoclonal antibody. Morolimumab can be used for the research of immune disease.
    Morolimumab
  • HY-P99771
    Onercept 199685-57-9
    Onercept is a recombinant soluble human tumor necrosis factor-alpha p55 receptor for use in Crohn's disease research.
    Onercept
  • HY-P99775
    Placulumab 945781-29-3
    Placulumab (ART621) is an anti-TNF α monoclonal antibody. Placulumab has anti-inflammatory activity and has potential applications in inflammatory diseases such as arthritis.
    Placulumab
  • HY-P99790
    Priliximab 147191-91-1
    Priliximab (CEN 000029) is an anti-CD4 humanized monoclonal antibody. Priliximab binds to CD4 on the surface of T cells, resulting in a significant and sustained reduction in circulating CD4+ T cells. Priliximab can be used in research of rheumatoid arthritis (RA).
    Priliximab
Cat. No. Product Name / Synonyms Application Reactivity